Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous ...
Approval for children aged two to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical study programCSU is a chronic skin ...
The FDA has expanded approval of dupilumab to include children aged 2 to 11 years with chronic spontaneous urticaria who ...
Alabama Lt. Gov. Will Ainsworth advised other outdoorsmen to proceed with caution after he recently tested positive for Rocky ...
FDA expands Dupixent approval for children aged 2 to 11 years with chronic spontaneous urticaria symptomatic despite H1 antihistamine use.
Approval for children aged 2 to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical trial program ...
Approval for children aged 2 to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical trial program CSU is a chronic skin ...
The FDA has extended the approval of dupilumab to children aged 2-11 years with chronic spontaneous urticaria (CSU) who remain symptomatic despite treatment with histamine 1 antihistamines (H1AH), ...
Colorectal cancer is projected to impact more than 158,000 Americans in 2026. Learn about an immunotherapy-based treatment ...
You can’t get shingles in your 20s,” her mom told her. Still, Pipps went to her dad for a second opinion. “My dad took one ...
A Wiltshire mum is calling for better labelling of cleaning products after her son’s skin came out in a severe rash.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results